← back to search

Henrik Flyger

National Institutes of Health · US
Area of research
Genetics · Molecular Biology
Research interest
Research interests include BRCA gene mutations in cancer, Genetic Associations and Epidemiology, Breast Cancer Treatment Studies, and Genomics and Chromatin Dynamics.
h-index
45
citations
12,885
works
123
NIH funding
primary concept
email

Recent publications

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
Nature Communications 2025cited by 7position: middledoi
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
medRxiv 2024cited by 3position: middledoi
The impact of coding germline variants on contralateral breast cancer risk and survival
The American Journal of Human Genetics 2023cited by 26position: middledoi
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
Journal of Clinical Oncology 2023cited by 26position: middledoi
Association of the <scp> <i>CHEK2</i> </scp> c. <scp>1100delC</scp> variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
Cancer Medicine 2023cited by 10position: middledoi
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
Journal of Medical Genetics 2023cited by 5position: middledoi
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
Cancers 2023cited by 1position: middledoi
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
British Journal of Sports Medicine 2022cited by 96position: middledoi
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients
Breast Cancer Research 2022cited by 19position: middledoi
Rare germline copy number variants (CNVs) and breast cancer risk
Communications Biology 2022cited by 14position: middledoi
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~200,000 patients
Research Square 2022cited by 2position: middledoi
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium
Cancer Epidemiology Biomarkers & Prevention 2021cited by 40position: middledoi
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
British Journal of Cancer 2021cited by 22position: middledoi
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
Breast Cancer Research 2021cited by 22position: middledoi
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
The American Journal of Human Genetics 2021cited by 12position: middledoi
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
British Journal of Cancer 2021cited by 9position: middledoi
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
medRxiv 2021cited by 5position: middledoi
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
Scientific Reports 2021cited by 4position: middledoi
Rare copy number variants (CNVs) and breast cancer risk
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 0position: middledoi
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
The American Journal of Human Genetics 2020cited by 67position: middledoi
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Nature Communications 2020cited by 47position: middledoi
Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status
Genetic Epidemiology 2020cited by 45position: middledoi
Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts
Breast Cancer Research and Treatment 2020cited by 23position: middledoi
Common Susceptibility Loci for Male Breast Cancer
JNCI Journal of the National Cancer Institute 2020cited by 20position: middledoi
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
Scientific Reports 2020cited by 5position: middledoi
Genome-wide association study of germline variants and breast cancer-specific mortality
British Journal of Cancer 2019cited by 73position: middledoi
Prediction and clinical utility of a contralateral breast cancer risk model
Breast Cancer Research 2019cited by 40position: middledoi
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 13position: middledoi
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
The American Journal of Human Genetics 2018cited by 1,166position: middledoi
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Nature Genetics 2018cited by 246position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.